Skip to main content
. 2023 Jul 31;25:44. doi: 10.1186/s12968-023-00951-y

Table 1.

Patient characteristics

Characteristic Value
Age 12.0 [10.4–16.3]
Height (cm) 145 [127–158]
Weight (kg) 47.8 [35.6–64.5]
BSA calculated (Haycock) 1.4 [1.2–1.7]
Race

 Caucasian

 African American

 Asian

 Other

43 (92%)

3 (6%)

2 (4%)

1 (2%)
Ethnicity
 Hispanic/Latino 6 (12%)
Medications

 Steroids

 ACEi

 Beta-blocker

 Aldactone

 ARB

 Aspirin

 Lasix

31 (63%)

26 (53%)

13 (27%)

6 (12%)

3 (6%)

3 (6%)

1 (2%)
LV ejection fraction (%) 59 [54–61]
LV cardiac index (L/min/m2) 3.5 [3.0–4.2]
Indexed LV end diastolic volume (ml/m2) 61 [55–73]
Indexed LV end systolic volume (ml/m2) 25 [22–32]
LV mass indexed (g/m2) 45 [41–52]
RV ejection fraction (%) 59 [55–62]

Late Gadolinium Enhancement

 Basal anterior

 Basal anteroseptal

 Basal inferoseptal

 Basal inferior

 Basal inferolateral

 Basal anterolateral

 Mid anterior

 Mid anteroseptal

 Mid inferoseptal

 Mid inferior

 Mid inferolateral

 Mid anterolateral

 Apical anterior

 Apical septal

 Apical inferior

 Apical lateral

 Apex

31 (63%)

11 (22%)

7 (14%)

7 (14%)

21 (43%)

28 (57%)

27 (55%)

9 (18%)

5 (10%)

9 (18%)

22 (45%)

30 (61%)

28 (57%)

10 (20%)

9 (18%)

11 (22%)

14 (29%)

7 (14%)

Patient characteristics and measurements at first cardiac MRI for 49 patients. Continuous variables presented as median [IQR] and categorical variables as count (frequency). ACEi Angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker, BSA body surface area, LV left ventricle, RV right ventricle